Filing Flows › Rapid Micro Biosystems (RPID) › Q3 2025
Rapid Micro Biosystems (RPID) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 7, 2025
Rapid Micro Biosystems (RPID) reported revenue of $7.8M for the third quarter 2025 (Q3 2025), +3% from a year earlier and +8% from the quarter before. Operating margin was -145.1%, net loss $11.5M (146.8% of revenue).
Rapid Micro Biosystems, Q3 2025: revenue $7.8M (+3% year over year), operating margin -145.1%, net loss $11.5M, operating cash flow −$9.1M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.8M | +8% | +3% |
| Operating profit | −$11.4M | — | — |
| Net earnings | −$11.5M | — | — |
| Operating cash flow | −$9.1M | — | — |
What changed
Revenue was $7.8M in Q3 2025, up 3% year over year and up 8% from the previous quarter. Product was the largest line at 67% of revenue. Service added $275K year over year (up 12%), 118% of the total change. Product declined 1%.
Operating costs exceeded revenue by $11.4M, an operating margin of -145.1%. Total costs fell 2% while revenue rose 3%. The quarter ended with a net loss of $11.5M, narrower than the previous quarter's $11.9M loss.
Operating cash flow was −$9.1M. Non-cash charges added back $804K of depreciation and amortization and $1.1M of share-based compensation. Working capital and other items added $504K. Capital expenditures of $73K exceeded it, leaving free cash flow of −$9.1M.
Questions
What was Rapid Micro Biosystems' revenue in the third quarter 2025?
Rapid Micro Biosystems (RPID) reported revenue of $7.8M for the third quarter 2025 (Q3 2025), +3% from a year earlier and +8% from the quarter before.
Was Rapid Micro Biosystems profitable in the third quarter 2025?
Operating loss was $11.4M (-145.1% of revenue) and net loss $11.5M.